Methadone in Pediatric and Adult Sickle Cell Patients
Status: | Recruiting |
---|---|
Conditions: | Anemia |
Therapuetic Areas: | Hematology |
Healthy: | No |
Age Range: | 7 - 40 |
Updated: | 6/18/2016 |
Start Date: | January 2008 |
End Date: | December 2017 |
To determine the pharmacokinetics of methadone in children and adults with SCD who are
experiencing a painful episode.
experiencing a painful episode.
Inclusion Criteria:
- Greater than or equal to 7 years and less than or equal to 40 years
- Confirmed diagnosis of any form of sickle cell disease, including sickle cell anemia,
sickle-hemoglobin C disease, and sickle-B thalassemia
- Currently experiencing a vaso-occlusive episode (VOE), defined as acute pain in the
extremities
- Admitted to the inpatient unit for further treatment
- Started on morphine patient controlled analgesia and infusion for pain management
Exclusion Criteria:
- Diagnosis of acute chest syndrome
- New focal neurologic findings or clinical concern of stroke
- Aplastic crisis with hemoglobin 2 g/dl below steady-state value
- Allergy to morphine or methadone
- Any other medical condition that the attending physician deems to be a
contraindication to therapy
- Liver or renal insufficiency or failure, and congestive heart failure
We found this trial at
1
site
St. Louis, Missouri 63110
Principal Investigator: Evan D Kharasch, MD, PhD
Phone: 314-362-7551
Click here to add this to my saved trials